Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/24558
Title: | Endothelial dysfunction – a major mediator of diabetic vascular disease | Authors: | Sena, Cristina M. Pereira, Ana M. Seiça, Raquel |
Keywords: | Endothelial dysfunction; Endothelium; Diabetes; Vascular function; Oxidative stress; Potential therapeutic target | Issue Date: | Dec-2013 | Publisher: | Elsevier | Citation: | SENA, Cristina M.; PEREIRA, Ana M.; SEIÇA, Raquel - Endothelial dysfunction — A major mediator of diabetic vascular disease. "Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease". ISSN 0925-4439. Vol. 1832, nº 12 (2013) p. 2216-2231. | Serial title, monograph or event: | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | Volume: | 1832 | Issue: | 12 | Abstract: | The vascular endothelium is a multifunctional organ and is critically involved in modulating vascular tone and structure. Endothelial cells produce a wide range of factors that also regulate cellular adhesion, thromboresistance, smooth muscle cell proliferation, and vessel wall inflammation. Thus, endothelial function is important for the homeostasis of the body and its dysfunction is associated with several pathophysiological conditions, including atherosclerosis, hypertension and diabetes. Patients with diabetes invariably show an impairment of endothelium-dependent vasodilation. Therefore, understanding and treating endothelial dysfunction is a major focus in the prevention of vascular complications associated with all forms of diabetes mellitus. The mechanisms of endothelial dysfunction in diabetes may point to new management strategies for the prevention of cardiovascular disease in diabetes. This review will focus on the mechanisms and therapeutics that specifically target endothelial dysfunction in the context of a diabetic setting. Mechanisms including altered glucose metabolism, impaired insulin signaling, low-grade inflammatory state, and increased reactive oxygen species generation will be discussed. The importance of developing new pharmacological approaches that upregulate endothelium-derived nitric oxide synthesis and target key vascular ROS-producing enzymes will be highlighted and new strategies that might prove clinically relevant in preventing the development and/or retarding the progression of diabetes associated vascular complications. | URI: | https://hdl.handle.net/10316/24558 | ISSN: | 0925-4439 | DOI: | 10.1016/j.bbadis.2013.08.006 | Rights: | openAccess |
Appears in Collections: | FMUC Medicina - Artigos em Revistas Internacionais I&D IBILI - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Endothelial dysfunction.pdf | 1.16 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
643
checked on Oct 7, 2024
WEB OF SCIENCETM
Citations
1
539
checked on May 2, 2023
Page view(s) 20
697
checked on Oct 8, 2024
Download(s) 20
1,221
checked on Oct 8, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.